145 related articles for article (PubMed ID: 32118269)
1. Detection of anti-Mi-2 autoantibodies before dermatomyositis-specific manifestations.
Vulsteke JB; Blockmans D; Moons V; Vijgen S; Bossuyt X; De Langhe E
Rheumatology (Oxford); 2020 Oct; 59(10):e60-e62. PubMed ID: 32118269
[No Abstract] [Full Text] [Related]
2. Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.
Nandy A; Gaïni S; Sore P
Scand J Rheumatol; 2018 Jul; 47(4):334-335. PubMed ID: 29043891
[No Abstract] [Full Text] [Related]
3. Vocal cord palsy in refractory anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis.
Alsaed OS; Alamlih LI; Farfar KA; Mohd TRN; Alemadi SAAR; Malallah HA
Rheumatology (Oxford); 2020 Oct; 59(10):e66-e67. PubMed ID: 32252065
[No Abstract] [Full Text] [Related]
4. Dermatomyositis with anti-TIF1-γ antibodies.
De Greef A; Marot L; Yildiz H; Baeck M
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30297488
[No Abstract] [Full Text] [Related]
5. Acquired Partial Lipodystrophy Associated with Anti-Mi-2 Antibody-positive Adult-onset Dermatomyositis.
Shiraishi K; Tohyama M; Sayama K
Acta Derm Venereol; 2019 Jan; 99(1):95-96. PubMed ID: 30182133
[No Abstract] [Full Text] [Related]
6. Three cases of autoimmune-associated haemophagocytic syndrome in dermatomyositis with anti-MDA5 autoantibody.
Honda M; Moriyama M; Kondo M; Kumakura S; Sumita Y; Murakawa Y
Scand J Rheumatol; 2020 May; 49(3):244-246. PubMed ID: 31571515
[No Abstract] [Full Text] [Related]
7. Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
Conway R; O'Donnell R; Fahy R; Doran MF; Cunnane G; O'Shea FD
QJM; 2014 Jul; 107(7):593-4. PubMed ID: 24336848
[No Abstract] [Full Text] [Related]
8. [Dermatomyositis and Autoantibodies].
Fujimoto M
Brain Nerve; 2018 Apr; 70(4):427-438. PubMed ID: 29632290
[TBL] [Abstract][Full Text] [Related]
9. [Dermatomyositis-specific antibodies].
Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
[TBL] [Abstract][Full Text] [Related]
10. [Anti-MI-2 antibody as a specific marker of dermatomyositis].
Kowalska-Oledzka E; Jarzabek-Chorzelska M; Kołacińska-Strasz Z
Neurol Neurochir Pol; 1995; 29(5):703-11; discussion 712. PubMed ID: 8584096
[TBL] [Abstract][Full Text] [Related]
11. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
12. Universalis Calcinosis in Adult Dermatomyositis: An "Anti-NXP2 Syndrome".
Fodil D; Meyer A; Salah SS; Sibilia J; Attal N; Tafiani-Lefkir S
J Clin Rheumatol; 2016 Oct; 22(7):387-9. PubMed ID: 27660942
[No Abstract] [Full Text] [Related]
13. Macromolecular creatine kinase Type 1 in a patient with anti-aminoacyl-tRNA synthetase autoantibody-related dermatomyositis.
Horino T; Inotani S; Matsumoto T; Ichii O
QJM; 2020 Mar; 113(3):201-202. PubMed ID: 31599957
[No Abstract] [Full Text] [Related]
14. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
15. Dermatomyositis and malignant melanoma: a rare association that worsens prognosis?
Fernández-Crehuet P; Pérez-Gil A; Herrera-Saval A; Cantalejo-Rodríguez C; Ríos-Martín JJ; Camacho-Martínez FM
Intern Med J; 2014 Oct; 44(10):1041-3. PubMed ID: 25302726
[No Abstract] [Full Text] [Related]
16. [Recent findings in dermatomyositis-specific autoantibodies].
Fujimoto M
Rinsho Shinkeigaku; 2014; 54(12):1110-2. PubMed ID: 25672722
[TBL] [Abstract][Full Text] [Related]
17. Retinal involvement in patients with juvenile dermatomyositis.
Brusco M; Hug D; Lasky A; Hoeltzel M
J Pediatr Ophthalmol Strabismus; 2010 Sep; 47 Online():e1-4. PubMed ID: 20886808
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
19. Antihelix/helix violaceous macules in Japanese patients with anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis.
Okiyama N; Inoue S; Saito A; Nakamura Y; Ishitsuka Y; Fujisawa Y; Watanabe R; Fujimoto M
Br J Dermatol; 2019 May; 180(5):1226-1227. PubMed ID: 30431155
[No Abstract] [Full Text] [Related]
20. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
